Figure 2. Two screenshots of the MSC interface.

Patient-specific guidelines for codeine are shown for a hypothetical patient who has pharmacogenetic test results available that identify him as “CYP2D6 ultrarapid metabolizer” and “TPMT poor metabolizer.” The screenshots depict the version of the user interface that was used during the pilot interviews with pharmacists.